This protocol is judged by an institutional critique board, an impartial group that evaluations any clinical trials involving humans. If a research requires a Routine I drug, after the board approves the protocol as ethical, the scientists really need to make an application for an investigational new drug (IND) amount from the FDA.Though the protoc